{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:37:35Z","timestamp":1792795055046,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100013015","name":"Cedars-Sinai Medical Center","doi-asserted-by":"publisher","award":["228019"],"award-info":[{"award-number":["228019"]}],"id":[{"id":"10.13039\/100013015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.humimm.2020.04.003","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T23:32:36Z","timestamp":1587079956000},"page":"330-336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["HLA-DQ mismatches stimulate de novo donor specific antibodies in heart transplant recipients"],"prefix":"10.1016","volume":"81","author":[{"given":"Xiaohai","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Kransdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jignesh K.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon A.","family":"Kobashigawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2020.04.003_b0005","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1600-6143.2010.03383.x","article-title":"De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival","volume":"11","author":"Smith","year":"2011","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2020.04.003_b0010","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13416","article-title":"De novo donor-specific HLA antibodies in heart transplantation: do transient de novo DSA confer the same risk as persistent de novo DSA?","volume":"32","author":"Moayedi","year":"2018","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.humimm.2020.04.003_b0015","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1161\/01.CIR.98.8.786","article-title":"Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation","volume":"98","author":"Itescu","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.humimm.2020.04.003_b0020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.trre.2018.05.002","article-title":"The clinical impact of donor-specific antibodies in heart transplantation","volume":"32","author":"Barten","year":"2018","journal-title":"Transplant Rev. (Orlando)"},{"key":"10.1016\/j.humimm.2020.04.003_b0025","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13033","article-title":"Donor-specific antibodies are associated with micro- and macrovascular coronary disease, restrictive myocardial damage, and poor outcome in heart-transplanted patients","volume":"31","author":"Clemmensen","year":"2017","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.humimm.2020.04.003_b0030","article-title":"HLA matching at the epitope level: the way to go","volume":"441","author":"Duquesnoy","year":"2013","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.humimm.2020.04.003_b0035","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1111\/ajt.13341","article-title":"The synergistic effect of class II HLA epitope-mismatch and nonadherence on acute rejection and graft survival","volume":"15","author":"Wiebe","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2020.04.003_b0040","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1111\/ajt.12478","article-title":"Class II HLA epitope matching-A strategy to minimize de novo donor-specific antibody development and improve outcomes","volume":"13","author":"Wiebe","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2020.04.003_b0045","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1681\/ASN.2017030287","article-title":"Class II eplet mismatch modulates tacrolimus trough levels required to prevent donor-specific antibody development","volume":"28","author":"Wiebe","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.humimm.2020.04.003_b0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/TP.0000000000001887","article-title":"Terasaki epitope mismatch burden predicts the development of de novo DQ donor-specific antibodies and are associated with adverse allograft outcomes","volume":"102","author":"Willicombe","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2020.04.003_b0055","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1111\/ajt.13798","article-title":"HLA matching at the eplet level protects against chronic lung allograft dysfunction","volume":"16","author":"Walton","year":"2016","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2020.04.003_b0060","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/lt.25286","article-title":"Class II human leukocyte antigen epitope mismatch predicts de novo donor-specific antibody formation after liver transplantation","volume":"24","author":"Kubal","year":"2018","journal-title":"Liver Transpl."},{"key":"10.1016\/j.humimm.2020.04.003_b0065","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/j.healun.2019.01.199","article-title":"HLA epitope mismatching is associated with rejection and worsened graft survival in heart transplant recipients","volume":"38","author":"Osorio-Jaramillo","year":"2019","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.humimm.2020.04.003_b0070","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.humimm.2012.12.004","article-title":"Predicted indirectly recognizable HLA epitopes presented by HLA-DR correlate with the de novo development of donor-specific HLA IgG antibodies after kidney transplantation","volume":"74","author":"Otten","year":"2013","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2020.04.003_b0075","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1111\/ajt.13508","article-title":"Predicted indirectly recognizable HLA epitopes presented by HLA-DRB1 are related to HLA antibody formation during pregnancy","volume":"15","author":"Geneugelijk","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2020.04.003_b0080","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1111\/ajt.14393","article-title":"Donor-recipient matching based on predicted indirectly recognizable HLA epitopes independently predicts the incidence of de novo donor-specific HLA antibodies following renal transplantation","volume":"17","author":"Lachmann","year":"2017","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2020.04.003_b0085","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.12924","article-title":"De novo DQ donor-specific antibodies are associated with worse outcomes compared to non-DQ de novo donor-specific antibodies following heart transplantation","volume":"31","author":"Cole","year":"2017","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.humimm.2020.04.003_b0090","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fimmu.2018.00321","article-title":"PIRCHE-II is related to graft failure after kidney transplantation","volume":"9","author":"Geneugelijk","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2020.04.003_b0095","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5144\/0256-4947.2018.97","article-title":"Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after heart transplantation","volume":"38","author":"Omrani","year":"2018","journal-title":"Ann. Saudi Med."},{"key":"10.1016\/j.humimm.2020.04.003_b0100","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.healun.2013.08.011","article-title":"The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation","volume":"32","author":"Berry","year":"2013","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.humimm.2020.04.003_b0105","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.humimm.2014.09.012","article-title":"First report on the antibody verification of HLA-DR, HLA-DQ and HLA-DP epitopes recorded in the HLA Epitope Registry","volume":"75","author":"Duquesnoy","year":"2014","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2020.04.003_b0110","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.healun.2014.07.014","article-title":"Effect of human leukocyte antigen-C and -DQ matching on pediatric heart transplant graft survival","volume":"33","author":"Butts","year":"2014","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.humimm.2020.04.003_b0115","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1111\/ajt.14951","article-title":"Identification of risk epitope mismatches associated with de novo donor-specific HLA antibody development in cardiothoracic transplantation","volume":"18","author":"McCaughan","year":"2018","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2020.04.003_b0120","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms6369","article-title":"Divergent paths for the selection of immunodominant epitopes from distinct antigenic sources","volume":"5","author":"Kim","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.humimm.2020.04.003_b0125","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0264-410X(94)90334-4","article-title":"An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination","volume":"12","author":"Cox","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.humimm.2020.04.003_b0130","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/TP.0000000000000545","article-title":"Memory B cells in transplantation","volume":"99","author":"Chong","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2020.04.003_b0135","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ebiom.2019.07.028","article-title":"Development and validation of a peripheral blood mRNA assay for the assessment of antibody-mediated kidney allograft rejection: a multicentre, prospective study","volume":"46","author":"Van Loon","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.humimm.2020.04.003_b0140","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1681\/ASN.2018111098","article-title":"A peripheral blood gene expression signature to diagnose subclinical acute rejection","volume":"30","author":"Zhang","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.humimm.2020.04.003_b0145","doi-asserted-by":"crossref","DOI":"10.1111\/tan.13307","article-title":"Inaccuracies in epitope repertoire estimations when using Multi-Locus Allele-Level hla genotype imputation tools","author":"D'Souza","year":"2018","journal-title":"HLA"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019888592030149X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019888592030149X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:53:07Z","timestamp":1759319587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019888592030149X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S019888592030149X"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2020.04.003","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HLA-DQ mismatches stimulate de novo donor specific antibodies in heart transplant recipients","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2020.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}